Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Jacob Shteyman

Weight-loss drugs not lights out for ResMed: CEO

ResMed says the emergence of weight-loss drugs will boost people seeking its products. (April Fonti/AAP PHOTOS)

Medical technology company ResMed continues to expand demand for its sleep apnoea devices, defying predictions growth in weight-loss drugs will undercut its market.

The Sydney-founded, California-domiciled company on Friday AEST reported revenue grew by nine per cent in the quarter ended June 30 to $US1.22 billion ($A1.88 billion), roughly in line with analyst expectations.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.